{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:45Z","timestamp":1761519105359},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,8]],"date-time":"2014-03-08T00:00:00Z","timestamp":1394236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40256-014-0066-3","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T12:53:04Z","timestamp":1394196784000},"page":"209-216","source":"Crossref","is-referenced-by-count":10,"title":["Cost Effectiveness of Eplerenone in Patients with Chronic Heart Failure"],"prefix":"10.1007","volume":"14","author":[{"given":"Zanfina","family":"Ademi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Pasupathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,8]]},"reference":[{"key":"66_CR1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1472-6963-12-434","volume":"12","author":"DH Smith","year":"2012","unstructured":"Smith DH, Johnson ES, Blough DK, Thorp ML, Yang X, Petrik AF, et al. Predicting costs of care in heart failure patients. BMC Health Serv Res. 2012;12:434.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"66_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013;113(6):646\u201359.","journal-title":"Circ Res"},{"issue":"J","key":"66_CR3","doi-asserted-by":"crossref","first-page":"J5","DOI":"10.1093\/eurheartj\/sui056","volume":"7","author":"M Tendera","year":"2005","unstructured":"Tendera M. Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe. Eur Heart J Suppl. 2005;7(J):J5\u20139.","journal-title":"Eur Heart J Suppl"},{"key":"66_CR4","unstructured":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated October 2011."},{"issue":"1","key":"66_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.hpc.0000154606.55424.fc","volume":"4","author":"E Herzog","year":"2005","unstructured":"Herzog E, Varley C, Kukin M. Pathway for the management of acute heart failure. Crit Pathw Cardiol. 2005;4(1):37\u201342.","journal-title":"Crit Pathw Cardiol"},{"issue":"9667","key":"66_CR6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(09)60236-1","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Abraham WT. Heart failure. Lancet. 2009;373(9667):941\u201355.","journal-title":"Lancet"},{"key":"66_CR7","unstructured":"AIHW. National Hospital Morbidity Database: separation statistics by principal diagnosis in ICD-10-AM, Australia, 2008\u201309 to 2009\u201310; 2011. http:\/\/www.aihw.gov.au\/hospitals-data-cube\/?id=10737419429 . Accessed 8 May 2011."},{"issue":"1","key":"66_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCOUTCOMES.109.854760","volume":"3","author":"DJ Whellan","year":"2010","unstructured":"Whellan DJ, Greiner MA, Schulman KA, Curtis LH. Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004. Circ Cardiovasc Qual Outcomes. 2010;3(1):33\u201340.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"66_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"66_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","volume":"13","author":"A Briggs","year":"1998","unstructured":"Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. PharmacoEconomics. 1998;13:397\u2013409.","journal-title":"PharmacoEconomics"},{"key":"66_CR11","unstructured":"National GRIM books. Australian Institute of Health and Welfare. http:\/\/www.aihw.gov.au\/national-grim-books\/ Accessed Feb 2013."},{"key":"66_CR12","doi-asserted-by":"crossref","unstructured":"Ford E, Adams J, Graves N. Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia. BMJ Open. 2012;2(5):pii:e001094.","DOI":"10.1136\/bmjopen-2012-001094"},{"issue":"1","key":"66_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehl382","volume":"28","author":"G Yao","year":"2007","unstructured":"Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007;28(1):42\u201351.","journal-title":"Eur Heart J"},{"key":"66_CR14","unstructured":"Department of Health and Ageing. AR-DRG version 6.0. Canberra: Australian government; 2012. http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/AR-DRG-Version_6.0 . Cited 31 Aug 12."},{"key":"66_CR15","unstructured":"Data collections. Public Sector Estimated Cost Weights Round 11 AR-DRG v5.1 (Excel 277\u00a0KB). http:\/\/www.healthemergency.gov.au\/internet\/main\/publishing.nsf\/Content\/Round_11-cost-reports . Accessed 18 April 2013."},{"key":"66_CR16","unstructured":"Australian Institute of Health and Welfare. http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=6442473791 . Accessed June 2013"},{"key":"66_CR17","unstructured":"Pharmaceutical Benefit Scheme (PBS). http:\/\/www.pbs.gov.au\/pbs\/home . Accessed 07 July 2013."},{"key":"66_CR18","unstructured":"Medicare Australia. http:\/\/www.mbsonline.gov.au\/ . Accessed 11 Dec 2013."},{"key":"66_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1524-4733.2004.74002.x","volume":"7","author":"JL Severens","year":"2004","unstructured":"Severens JL, Milne RJ. Discounting health outcomes in economic evaluation: the ongoing debate. Value Health. 2004;7:397\u2013401.","journal-title":"Value Health"},{"key":"66_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hec.4730030206","volume":"3","author":"A Briggs","year":"1994","unstructured":"Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;3:95\u2013104.","journal-title":"Health Econ"},{"key":"66_CR21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00019053-200523060-00001","volume":"23","author":"A O\u2019Hagan","year":"2005","unstructured":"O\u2019Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, et al. Incorporation of Uncertainty in Health Economic Modelling Studies. PharmacoEconomics. 2005;23:529\u201336.","journal-title":"PharmacoEconomics"},{"key":"66_CR22","unstructured":"Kirchmann K, Kirchmann M, Ademi Z, Stoelwinder J. Predictors of successfully listing on the PBS: a 2012 update. Poster presentation. ISPOR 5th Asia-Pacific conference, Taipei; 2012."},{"issue":"10","key":"66_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2165\/00019053-200523100-00008","volume":"23","author":"KF Croom","year":"2005","unstructured":"Croom KF, Plosker GL. Eplerenone: a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure. Pharmacoeconomics. 2005;23(10):1057\u201372.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"66_CR24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.acvd.2008.09.001","volume":"101","author":"G Pouvourville de","year":"2008","unstructured":"de Pouvourville G, Solesse A, Beillat M. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study. Arch Cardiovasc Dis. 2008;101(9):515\u201321.","journal-title":"Arch Cardiovasc Dis"},{"issue":"24","key":"66_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14240","volume":"14","author":"C McKenna","year":"2010","unstructured":"McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, et al. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. Health Technol Assess. 2010;14(24):1\u2013162.","journal-title":"Health Technol Assess"},{"issue":"3","key":"66_CR26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jval.2012.01.004","volume":"15","author":"C McKenna","year":"2012","unstructured":"McKenna C, Walker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, et al. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure. Value Health. 2012;15(3):420\u20138.","journal-title":"Value Health"},{"issue":"3","key":"66_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10557-006-8282-y","volume":"20","author":"TD Szucs","year":"2006","unstructured":"Szucs TD, Holm MV, Schwenkglenks M, Zhang Z, Weintraub WS, Burnier M, et al. Cost-effectiveness of eplerenone in patients with left ventricular dysfunction after myocardial infarction\u2014an analysis of the EPHESUS study from a Swiss perspective. Cardiovasc Drugs Ther. 2006;20(3):193\u2013204.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"66_CR28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.0000157146.86758.BC","volume":"111","author":"WS Weintraub","year":"2005","unstructured":"Weintraub WS, Zhang Z, Mahoney EM, Kolm P, Spertus JA, Caro J, et al. Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation. 2005;111(9):1106\u201313.","journal-title":"Circulation"},{"issue":"1","key":"66_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/11319940-000000000-00000","volume":"10","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Mahoney EM, Kolm P, Spertus J, Caro J, Willke R, et al. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS. Am J Cardiovasc Drugs. 2010;10(1):55\u201363.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"66_CR30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjmed.2011.12.018","volume":"125","author":"S Chatterjee","year":"2012","unstructured":"Chatterjee S, Moeller C, Shah N, Bolorunduro O, Lichstein E, Moskovits N, et al. Eplerenone is not superior to older and less expensive aldosterone antagonists. Am J Med. 2012;125(8):817\u201325.","journal-title":"Am J Med"},{"issue":"11","key":"66_CR31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/eurjhf\/hfp137","volume":"11","author":"OJ Wang","year":"2009","unstructured":"Wang OJ, Krumholz HM. Clinical trial participation: are we studying the patients we are trying to treat? Eur J Heart Failure. 2009;11(11):1021\u20132.","journal-title":"Eur J Heart Failure"},{"issue":"5","key":"66_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5694\/mja12.10993","volume":"199","author":"H Krum","year":"2013","unstructured":"Krum H, Driscoll A. Management of heart failure. Med J Aust. 2013;199(5):334\u20139.","journal-title":"Med J Aust"},{"issue":"4","key":"66_CR33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1524-4733.2007.00304.x","volume":"11","author":"R Elliott","year":"2008","unstructured":"Elliott R, Shinogle J, Peele P, Bhosle M, Hughes D. Understanding medication compliance and persistence from an economics perspective. Value Health. 2008;11(4):600\u201310.","journal-title":"Value Health"},{"issue":"2","key":"66_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0020-7489(99)00003-6","volume":"36","author":"A Ryan","year":"1999","unstructured":"Ryan A. Medication compliance and older people: a review of the literature. Int J Nurs Stud. 1999;36(2):153\u201362.","journal-title":"Int J Nurs Stud"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-014-0066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-014-0066-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-014-0066-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:42:28Z","timestamp":1565246548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-014-0066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,8]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s40256-014-0066-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,8]]}}}